Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04004091Phase 1Completed
Phase 1, open-label trial of Spermine in necrotizing enterocolitis (NEC) (6 arms). Primary endpoints: Occludin Expression at 2 weeks, Beta-catenin Expression at 2 weeks and 1 more. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04004091.